1. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197–1209.
2. Sucharda P. Abdominální obezita. Čas Lék Čes 2009; 148 (v tisku).
3. Sucharda P. Abdominální obezita – epidemie 21. století. Kardiol Rev 2008; 10: 165–167.
4. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International diabetes federation. Diabet Med 2006; 23: 469–480.
5. Rector RS, Thyfault JP, Wei Y et al. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol 2008; 14: 185–192.
6. Ketel IJ, Stehouwer CD, Serné EH et al. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 2008; 93: 3365–3372.
7. Eichinger S, Hron G, Bialonczyk C et al. Overweight, obesity, and the risk of recurrent venous thrombosis. Arch intern Med 2008; 168: 1678–1683.
8. Ageno W, Prandoni P, Romualdi E et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006; 4: 1914–1918.
9. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
10. Ay C, Tengler T, Vormittag R et al. Venous thromboembolism – a manifestation of the metabolic syndrome. Haematologica 2007; 92: 374–380.
11. Ray JG, Lonn E, Yi Q et al. Venous thromboembolism in association with features of the metabolic syndrome. Q J Med 2007; 100: 679–684.
12. Borch KH, Brækkan SK, Mathiesen EB et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome – the Tromsø study. J Thromb Haemost 2008; 22 [Epub ahead of print].
13. Sundell B, Nilsson TK, Randy M et al. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a crosssectional study in Norsjö, Sweden. J Clin Epidemiol 1989; 42: 719–723.
14. Landin K, Stigendal L, Eriksson E et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044–1048.
15. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158–161.